Henry Schein

Henry Schein is a global distributor of healthcare products and services, supplying pharmaceuticals, medical supplies, equipment, and technology solutions to office-based dental, medical, and animal health practitioners. The firm also provides value‑added offerings such as practice management software, educational resources, and consulting services to help providers manage their businesses. Its customer base spans North America, Europe, and other international markets, supported by a network of sales representatives and distribution centers.

The organization is headquartered in the United States of America. It is a publicly traded company listed on the NASDAQ under the ticker HSIC and is recognized as a Fortune 500 enterprise. Henry Schein organizes its operations into three core segments—Dental, Medical, and Animal Health—each with dedicated sales forces and logistics infrastructure.

A distinguishing attribute of Henry Schein is its ability to combine broad product sourcing with proprietary technology platforms that integrate directly into clinical workflows. Longstanding relationships with manufacturers enable the firm to offer competitive pricing and reliable availability of both branded and private‑label items. The company positions itself as a one‑stop source for healthcare providers seeking both clinical supplies and business support tools.

In October 2023, Henry Schein disclosed a cybersecurity incident that disrupted portions of its manufacturing and distribution operations, prompting temporary system takedowns and business interruptions. The company engaged external cybersecurity experts and forensic investigators, notified law enforcement, and confirmed that its customer‑facing practice management software remained unaffected. The disclosure was made in accordance with new SEC regulations, and a ransomware group later threatened to release data allegedly obtained during the breach.